Yong‐Moon Park

Federal Grant PI High Impact

Assistant Professor

UAMS

Also affiliated: Inje University (2021); Gachon University (2017); National Institutes of Health (2015–2023); IBM (United States) (1975); Ewha Womans University (2014); Soongsil University (2022–2025); University of South Carolina (2013–2017); University of Sassari (2021); Yonsei University (1977–2022); Korea University (2015); Princeton University (1989); Washington University in St. Louis (2009–2026); University of Arkansas Medical Center (2024); Korea University Medical Center (2015); Kyung Hee University (1997–2020); St Vincent's Hospital Melbourne (2016); Gachon University Gil Medical Center (2017–2024); The Catholic University of Korea St. Vincent's Hospital (2013–2022); National Institute of Environmental Health Sciences (2015–2023); Inje University Haeundae Paik Hospital (2011); Ajou University Hospital (2016); The Catholic University of Korea Yeouido St. Mary's Hospital (2016–2018); Inje University Busan Paik Hospital (2021–2022); Kyung Hee University Medical Center (2020); IBM Research - Thomas J. Watson Research Center (1975); Korea Disease Control and Prevention Agency (2012); The Catholic University of Korea Seoul St. Mary's Hospital (2014–2017); Korea Center for Disease Control and Prevention (2012); Alvin J. Siteman Cancer Center (2025); Korea University Anam Hospital (2015–2016); Ajou University (2016); Jeonbuk National University (1995); Institut des Hautes Études Scientifiques (1980–1994); The University of Texas Southwestern Medical Center (2022); Catholic University of Korea (1996–2022)

Epidemiology, College of Public Health

53 h-index 416 pubs 9,999 cited

Research Areas

Biomedical Subjects

Links

ORCID Google Scholar Research Group UAMS TRI Profile

OverviewAI-generated summary

Yong-Moon Park is an Assistant Professor in the Department of Epidemiology at the University of Arkansas for Medical Sciences. His research focuses on the epidemiology of chronic diseases, particularly diabetes and cardiovascular outcomes, and factors influencing health and mortality in diverse populations. He has investigated the predictive value of metabolic syndrome and the product of triglycerides and glucose for type 2 diabetes, as well as the associations of variability in blood pressure, glucose, cholesterol, and body mass index with mortality and cardiovascular outcomes. Park has also explored the relationship between diet quality scores and the risk of frailty and mortality, and the association of exposure to artificial light at night with obesity risk in women.

His work also includes examining the determinants of blood pressure in older Koreans, specifically the role of sarcopenia. Park is a highly cited researcher with an h-index of 52 and over 445 publications, accumulating more than 10,000 citations. He is a Principal Investigator on federally funded research, including a $155,260 grant from the NIH/National Heart Lung and Blood Institute to understand disparities in cardiovascular toxicity among breast cancer survivors in Arkansas. He leads a research group and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Mario Schootman and Jong Ha Baek.

Metrics

h-index: 53
Publications: 416
Citations: 9,999

Positions

Associate Professor 2021–present

University of Arkansas for Medical Sciences Department of Epidemiology ORCID
Assistant Professor publications 2015–2026

University of Arkansas for Medical Sciences Epidemiology, College of Public Health Institutional directory

Selected Publications

Association Between Adult Food Security Status and Body Weight Outcomes in U.S. Adults ≥40 Years: NHANES 2017–March 2020 (2026)

DOI OpenAlex
Intellectual developmental disability and risk of developing depression in type 2 diabetes (2026)

DOI OpenAlex
Short- and Long-Term Risks of Atrial Fibrillation in Surgically Treated Lung Cancer Patients: A Korean Nationwide Study (2026)

DOI OpenAlex
Abstract 7642: Nicotine dependence partially mediates the association between <i>IP6K3</i> genetic variation and risk of lung squamous cell carcinoma among smokers (2026)

DOI OpenAlex
Abstract 884: Waist-hip ratio (WHR) defined obesity phenotype and risk of diabetes in cancer survivor women from Sister Study. (2026)

DOI OpenAlex
26-A-16745-ACC POST-TRAUMATIC STRESS DISORDER AND MAJOR CARDIOVASCULAR OUTCOMES:A REAL-WORLD ANALYSIS (2026)

Journal of the American College of Cardiology DOI OpenAlex
Income Persistence and the Risk of Hepatocellular Carcinoma in Individuals with Type 2 Diabetes (2026)

DOI OpenAlex
Delay in breast cancer surgery: evaluating patient, healthcare access, and social vulnerability predictors (2026)

DOI OpenAlex
Association between intellectual disability and autism spectrum disorder with kidney failure (2026)

DOI OpenAlex
Risk of End-Stage Kidney Disease in Individuals with Diabetes Living Alone: A Large-Scale Population-Based Study (2025)

1 citation DOI OpenAlex
Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study (2025)

3 citations DOI OpenAlex
Carcinogenic air pollutants and breast cancer risk in the Arkansas rural community health study: A nested case-control study (2025)

2 citations DOI OpenAlex
Weight Changes and Heart Failure Risk After Breast Cancer Development (2025)

2 citations DOI OpenAlex
Weight change and cardiovascular disease incidence in breast cancer survivors: a nationwide cohort study (2025)

3 citations DOI OpenAlex
Changes in Physical Activity and Cardiovascular Disease Risk in Cancer Survivors (2024)

JACC CardioOncology 16 citations DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $155,260 total

NIH Contact PI Aug 2024 - Jul 2028

Understanding disparities in cardiovascular toxicity among breast cancer survivors in Arkansas

National Heart Lung and Blood Institute $155,260 K01

Research Interests

My research focuses on uncovering causes and preventive strategies for chronic diseases, including breast and other cancers, obesity, diabetes, hypertension, metabolic syndrome, and cardiovascular disease. I study how lifestyle factors (diet and exercise), genetics/epigenetics, social determinants of health, and environmental exposures influence disease risk and prognosis, and how these factors interact with each other. I also aims to reduce cardiovascular health disparities in cancer survivors.; Cancer Epidemiology; Nutritional Epidemiology; Cardiometabolic Disease (Obesity, Type 2 Diabetes, Hypertension, and Metabolic Syndrome); Cardiovascular Disease Epidemiology; Epidemiology of Cardio-Oncology; Social Determinants of Health; Clinical Epidemiology; Environmental Epidemiology; Genetic and Molecular Epidemiology; Chronic Disease Prevention

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

Enhancing Prediction of Cardiovascular Toxicity in Breast Cancer Survivors: A Comprehensive Machine Learning Approach Integrating Comorbidity Networks The Arkansas Breast Cancer Research Program Principal Investigator
The influence of ß-carotene supplements, dietary and circulating carotenoids on oxidative stress, inflammation, and risk of postmenopausal breast cancer in the Sister Study NIH Office of Dietary Supplements Principal Investigator
Promoting scientific and workforce diversity by enriching the Arkansas Rural Community Health Study (ARCH) among Mother-Daughter Pairs NIH Co-Investigator
Diet Quality and Epigenetic Modifications in Breast Cancer Development State of Arkansas, Arkansas Breast Cancer Research Program Principal Investigator
Association between Heavy Metal Exposure and Mammographic Density in an Underserved Populations in Arkansas TRI Translational Research Institute Principal Investigator